Title : Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis.

Pub. Date : 2022 Apr

PMID : 35178861






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis. Colchicine NLR family pyrin domain containing 3 Homo sapiens
2 The anti-inflammatory drug colchicine exerts its effects, in part, via reducing NLRP3 activity, and has been shown to improve several cardiac diseases, including acute coronary syndrome and pericarditis. Colchicine NLR family pyrin domain containing 3 Homo sapiens
3 Evaluation of components of the NLRP3 inflammasome revealed an increased percentage of apoptosis-associated speck-like protein containing a CARD domain (ASC)-expressing, caspase-1-expressing, and interleukin-1beta-expressing cells in the myocardium and in the spleen of CVB3 + PBS vs. control mice, which was reduced in CVB3 + colchicine compared with CVB3 + PBS mice. Colchicine NLR family pyrin domain containing 3 Homo sapiens
4 In both CVB3 FB and HL-1 cells, colchicine down-regulated the NLRP3 inflammasome-related components ASC, caspase-1, and IL-1beta. Colchicine NLR family pyrin domain containing 3 Homo sapiens
5 CONCLUSIONS: Colchicine improves LV function in CVB3-induced myocarditis, involving a decrease in cardiac and splenic NLRP3 inflammasome activity, without exacerbation of CVB3 load. Colchicine NLR family pyrin domain containing 3 Homo sapiens